Przejdź do zawartości
Merck

Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery.

Journal of investigative surgery : the official journal of the Academy of Surgical Research (2014-09-03)
Andreas Alexandrou, Eleni Armeni, George Kaparos, Demetrios Rizos, Evangelia Tsoka, Efthymios Deligeoroglou, Maria Creatsa, Areti Augoulea, Theodoros Diamantis, Irene Lambrinoudaki
ABSTRAKT

To evaluate the association between the Bsm1 vitamin D receptor polymorphism and the calcium-vitamin D-parathormone axis following bariatric surgery. This cross-sectional study included 86 morbidly obese patients, who underwent either gastric bypass or sleeve gastrectomy, with a mean follow-up of four years. Calcium metabolism indices and bone turnover markers were assessed according to the presence of secondary hyperparathyroidism and the Bsm1 vitamin D receptor genotypes. Secondary hyperparathyroidism (42.2% of sample) was associated with lower levels of 25hydroxyvitamin D and elevated markers of bone turnover. In subjects without secondary hyperparathyroidism, presence of the unfavorable B allele resulted in higher levels of parathormone (Bb and BB vs. bb genotype: 50.3 ± 8.2 pg/dl vs. 44.4 ± 10.7 pg/dl, p = .011, adjusted for weight loss, baseline body mass index, 25hydroxyvitamin D, surgical procedure, and duration after surgery). In the whole sample, patients bearing the unfavorable B allele exhibited lower weight loss, a parameter that was negatively associated with markers of bone resorption. Secondary hyperparathyroidism is highly prevalent after bariatric surgery. Bsm1 vitamin D receptor polymorphism may have an effect in early stages of calcium metabolism imbalance, while no association is detected in patients who have already developed secondary hyperparathyroidism. Moreover, vitamin D receptor polymorphism is associated with post-surgery weight loss, a process related to bone turnover.

MATERIAŁY
Numer produktu
Marka
Opis produktu

USP
Acetaminofen, United States Pharmacopeia (USP) Reference Standard
USP
Omeprazole, United States Pharmacopeia (USP) Reference Standard
Furosemide for peak identification, European Pharmacopoeia (EP) Reference Standard
Fluorescein, European Pharmacopoeia (EP) Reference Standard
Supelco
Acetaminophen, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Omeprazole, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Furosemide, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
2,6-Diisopropylphenol, 97%
Sigma-Aldrich
Rocuronium bromide, ≥97% (perchloric acid titration)
USP
Furosemide, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Acetaminophen, BioXtra, ≥99.0%
Sigma-Aldrich
Acetaminophen, analytical standard
Sigma-Aldrich
Omeprazole, solid
Sigma-Aldrich
β-D-Allose, rare aldohexose sugar
Sigma-Aldrich
Furosemide
Sigma-Aldrich
Fluorescein, suitable for fluorescence, free acid
Sigma-Aldrich
Acetaminophen, meets USP testing specifications, 98.0-102.0%, powder
Omeprazole for peak identification, European Pharmacopoeia (EP) Reference Standard
Supelco
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Rocuronium bromide, European Pharmacopoeia (EP) Reference Standard
Omeprazole, European Pharmacopoeia (EP) Reference Standard
Furosemide, European Pharmacopoeia (EP) Reference Standard
Supelco
Omeprazole, analytical standard
Propofol for peak identification, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
SyntheChol® NS0 Supplement, 500 ×, synthetic cholesterol, animal component-free, sterile-filtered, aqueous solution, suitable for cell culture
Supelco
Lidocaine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Budesonide, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Hydrogen chloride – 2-propanol solution, ~1.25 M HCl (T), derivatization grade (GC derivatization), LiChropur
Sigma-Aldrich
Hydrochloric acid solution, ~6 M in H2O, for amino acid analysis
Supelco
Hydrogen chloride – ethanol, ~1.25 M HCl, derivatization grade (GC derivatization), LiChropur